Autism - Pipeline Review, H2 2018

Autism - Pipeline Review, H2 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H2 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape.

Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include childs sex, family history, fragile X syndrome, Tourette syndrome and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Autism - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Autism (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 6, 3, 21, 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Autism (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Autism (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Autism (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Autism (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Autism (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Autism (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Autism (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Autism (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction 4
Tourette Syndrome - Overview 5
Tourette Syndrome - Therapeutics Development 6
Tourette Syndrome - Therapeutics Assessment 11
Tourette Syndrome - Companies Involved in Therapeutics Development 18
Tourette Syndrome - Drug Profiles 22
Tourette Syndrome - Dormant Projects 64
Tourette Syndrome - Discontinued Products 65
Tourette Syndrome - Product Development Milestones 66
Appendix 76

List Of Tables

List of Tables
Number of Products under Development for Autism, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Target, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Autism - Pipeline by 4D Pharma PLC, H2 2018
Autism - Pipeline by AgeneBio Inc, H2 2018
Autism - Pipeline by APeT Holding BV, H2 2018
Autism - Pipeline by Bantam Pharmaceutical LLC, H2 2018
Autism - Pipeline by BioHealthonomics Inc, H2 2018
Autism - Pipeline by BrainStorm Cell Therapeutics Inc, H2 2018
Autism - Pipeline by Coronis NeuroSciences Ltd, H2 2018
Autism - Pipeline by Curemark LLC, H2 2018
Autism - Pipeline by Evgen Pharma Plc, H2 2018
Autism - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Autism - Pipeline by GW Pharmaceuticals Plc, H2 2018
Autism - Pipeline by Heptares Therapeutics Ltd, H2 2018
Autism - Pipeline by Immuron Ltd, H2 2018
Autism - Pipeline by Intra-Cellular Therapies Inc, H2 2018
Autism - Pipeline by Leading BioSciences Inc, H2 2018
Autism - Pipeline by MedDay SA, H2 2018
Autism - Pipeline by Omeros Corp, H2 2018
Autism - Pipeline by OptiNose US Inc, H2 2018
Autism - Pipeline by Ovensa Inc, H2 2018
Autism - Pipeline by RespireRx Pharmaceuticals Inc, H2 2018
Autism - Pipeline by Reviva Pharmaceuticals Inc, H2 2018
Autism - Pipeline by Sumitomo Chemical Co Ltd, H2 2018
Autism - Dormant Projects, H2 2018
Autism - Dormant Projects, H2 2018 (Contd..1), H2 2018
Autism - Discontinued Products, H2 2018

List Of Figures

List of Figures
Number of Products under Development for Autism, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Autism - Pipeline Review, H2 2018

Autism - Pipeline Review, H2 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H2 2018, provides an overview of the Autism (Central Nervous System)

USD 2000 View Report

Autism - Market Insight, Epidemiology and Market Forecast - 2027

DelveInsights Autism - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Autism epidemiology and market outlook for the 7MM.Markets Covered United

USD 6250 View Report

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018, provides an overview of the Idiopathic Pulmonary

USD 2000 View Report

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018, provides an overview

USD 2000 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available